Given the need for an effective, non-hormonal treatment for Genitourinary syndrome of menopause GSM) symptoms in breast cancer survivors, the reported efficacy of fractional CO2 laser as such a treatment in retrospective studies, the study aims to evaluate the efficacy of CO2 laser for the treatment of GSM in breast cancer patients, in a prospective, randomized, blinded, placebo-controlled trial.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in dryness
Timeframe: Follow up after 3 treatments and at 1 month, 3 months and 6 months after last treatment.
Change in dyspareunia
Timeframe: Follow up after 3 treatments and at 1 month, 3 months and 6 months after last treatment.